EUVIMEDEUVIMED entdecken
Systematische Übersicht

Positron Emission Tomography Imaging of Pheochromocytoma and Paraganglioma—18F-FDOPA vs Somatostatin Analogues

Andreas Ebbehoj iD, Peter Iversen, Stine Kramer, Kirstine Stochholm, Per Løgstrup Poulsen, Karin Hjorthaug, Esben Søndergaard iD

The Journal of Clinical Endocrinology & Metabolism · 21.01.2025 · 110 (2) · 303-316

DOI: 10.1210/clinem/dgae764 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 28.10.2024. Verfasst von Andreas Ebbehoj und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N DK-8200, Denmark. Hauptthemen laut MEDLINE: Pheochromocytoma, Paraganglioma, Adrenal Gland Neoplasms, Positron-Emission Tomography. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 81 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Functional imaging with positron emission tomography (PET) scans is an essential part of the diagnostic workup for pheochromocytoma and paraganglioma (PPGL). The purpose of this review is to (1) provide a brief overview of functional imaging for PPGL, (2) summarize selected present and older guideline and review recommendations, and (3) conduct a literature review on the diagnostic performance of the most used PET tracers for PPGL. Evidence Acquisition We conducted a systematic literature search in PubMed from January 2004 to August 2024 with the search string (“Pheochromocytoma” OR “Paraganglioma”) AND (“Positron Emission Tomography” OR “Radionuclide Imaging” OR (“PET” AND (“FDG” OR “DOTATOC” OR “DOTANOC” OR “DOTATATE” OR “DOPA” OR “FDOPA”))). Studies involving PET scans of at least 20 individuals with PPGL or at least 5 individuals in a rare, well-defined subgroup of PPGL (eg, sympathetic or head-neck paragangliomas and specific pathogenic variants) were included. Evidence Synthesis Seventy studies were identified of which 21 were head-to-head comparisons of at least 2 different PET tracers [18F-fluorodihydroxyphenylalanine, fluorodihydroxyphenylalanine positron emission tomography (18F-FDOPA), 68Ga-DOTA-conjugated somatostatin analogues, 68Ga-DOTA-conjugated somatostatin analogue positron emission tomography (68Ga-SSA), and 18F-fluorodeoxyglucose]. 18F-FDOPA had higher sensitivity for pheochromocytoma compared to 68Ga-SSA and equal sensitivity for metastatic pheochromocytoma. 18F-FDOPA and 68Ga-SSA had similar sensitivity for primary non-succinate dehydrogenase subunits (SDHx) sympathetic and head-neck paraganglioma. However, 68Ga-SSA had higher sensitivity for metastatic sympathetic and head-neck paraganglioma and for SDHx-related paraganglioma.

Conclusion

18F-FDOPA and 68Ga-SSA PET are both sensitive for localizing PPGL. However, 18F-FDOPA is the most sensitive for detecting pheochromocytoma, while 68Ga-SSA is superior to 18F-FDOPA for metastatic sympathetic and head-neck paraganglioma and SDHx-related paraganglioma.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaParagangliomaAdrenal Gland NeoplasmsPositron-Emission TomographySomatostatinHumansDihydroxyphenylalanineRadiopharmaceuticalsFluorodeoxyglucose F18

Stichwörter der Autor:innen

18F-fluorodeoxyglucose18F-fluorodihydroxyphenylalanine68Ga-DOTA-conjugated somatostatin analoguesparagangliomapheochromocytomapositron-emission tomographyreview

Substanzen

Dihydroxyphenylalaninefluorodopa F 18SomatostatinRadiopharmaceuticalsFluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus N DK-8200, Denmark.
  • Department of Nuclear Medicine and PET Center, Aarhus University Hospital, Aarhus N DK-8200, Denmark.
  • Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus N DK-8200, Denmark.

ORCID-Profile: Andreas Ebbehoj, Esben Søndergaard

Zitieren

APA

Ebbehoj, A., Iversen, P., Kramer, S., Stochholm, K., Poulsen, P. L., Hjorthaug, K., & Søndergaard, E. (2025). Positron Emission Tomography Imaging of Pheochromocytoma and Paraganglioma—18F-FDOPA vs Somatostatin Analogues. The Journal of Clinical Endocrinology & Metabolism, 110(2), 303-316. https://doi.org/10.1210/clinem/dgae764

Vancouver

Ebbehoj A, Iversen P, Kramer S, Stochholm K, Poulsen PL, Hjorthaug K, et al. Positron Emission Tomography Imaging of Pheochromocytoma and Paraganglioma—18F-FDOPA vs Somatostatin Analogues. The Journal of Clinical Endocrinology & Metabolism. 2025;110(2):303-316. doi:10.1210/clinem/dgae764

BibTeX
@article{Ebbehoj2025,
  author = {Ebbehoj, Andreas and Iversen, Peter and Kramer, Stine and Stochholm, Kirstine and Poulsen, Per Løgstrup and Hjorthaug, Karin and Søndergaard, Esben},
  title = {Positron Emission Tomography Imaging of Pheochromocytoma and Paraganglioma—18F-FDOPA vs Somatostatin Analogues},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {2},
  pages = {303--316},
  doi = {10.1210/clinem/dgae764}
}
Kostenlos starten →